Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-16,033
Closed -$3.87M 53
2019
Q4
$3.87M Sell
16,033
-623
-4% -$137K 0.04% 330
2019
Q3
$3.22M Buy
16,656
+7,194
+76% +$1.38M 0.04% 346
2019
Q2
$1.74M Sell
9,462
-130,384
-93% -$23.3M 0.02% 370
2019
Q1
$26.6M Buy
+139,846
New +$26.7M 0.27% 54
2018
Q4
Sell
-20,598
Closed -$4.27M 1177
2018
Q3
$4.27M Buy
+20,598
New +$4.06M 0.03% 332
2018
Q2
Sell
-4,200
Closed -$716K 1005
2018
Q1
$716K Buy
4,200
+2,200
+110% +$404K ﹤0.01% 693
2017
Q4
$348K Buy
+2,000
New +$354K ﹤0.01% 827
2017
Q2
Sell
-380,700
Closed -$62.5M 907
2017
Q1
$62.5M Buy
+380,700
New +$63.3M 0.5% 26
2016
Q4
Sell
-27,000
Closed -$4.5M 717
2016
Q3
$4.5M Buy
+27,000
New +$4.57M 0.04% 234
2016
Q2
Sell
-20,841
Closed -$3.13M 947
2016
Q1
$3.13M Sell
20,841
-75,557
-78% -$11.2M 0.03% 345
2015
Q4
$15.6M Sell
96,398
-9,999
-9% -$1.57M 0.14% 89
2015
Q3
$14.7M Buy
106,397
+64,897
+156% +$10.2M 0.15% 98
2015
Q2
$6.37M Buy
41,500
+3,400
+9% +$545K 0.06% 194
2015
Q1
$6.09M Buy
38,100
+24,761
+186% +$3.9M 0.06% 202
2014
Q4
$2.13M Buy
+13,339
New +$2.08M 0.03% 376

Other funds holding AMGN

HBK Investments's AMGN Position: Q1 2020 in Review

HBK Investments sold out of Amgen (AMGN) in Q1 2020, closing a stake of 16,033 shares — an estimated $3.87M sold.

HBK Investments first reported a position in AMGN in Q4 2014 and held it in 15 quarters. The position peaked at $62.5M in Q1 2017. 2,030 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • HBK Investments reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
  • HBK Investments sold 16,033 Amgen shares in Q1 2020, an estimated $3.87M.
  • HBK Investments first reported a position in Amgen in Q4 2014 and held it in 15 quarters.
  • HBK Investments's Amgen position peaked at $62.5M in Q1 2017.
  • 2,030 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on HBK Investments's 13F filing for Q1 2020, filed 15 May 2020.